In early November, we published a POV written by Intouch Solutions social media manager, Andrew Grojean, about Twitter’s expanded character limit. Med Ad News reached out to Grojean and asked for a more in-depth version of the article, and he was pleased to provide it.
What can you expect from the deeper dive? A new section on compliant tweets, plus additional context around what other non-pharma brands are doing and language from the FDA draft guidance on character-constrained messaging.
Read the new piece here.